Viking Therapeutics Logo

Viking Therapeutics

🇺🇸
VKTX
US92686J1060

Viking Therapeutics is a U.S.-based biopharmaceutical company specializing in the development of innovative, clinical therapeutics. The company is focused on novel drug candidates for metabolic and endocrine diseases, including obesity, NASH, and type 2 diabetes, with the goal of improving patient health and outcomes.

Next Quarterly Earnings

Wednesday, October 28, 2026
CW 44
After-Hours
In 62 days

After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

Quiet period starts on September 30, 2026

Stock Price

Frequently asked questions

When will Viking Therapeutics report its next quarterly earnings?

Viking Therapeutics is scheduled to report its next quarterly earnings on 10/28/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

When did Viking Therapeutics last report quarterly earnings?

Viking Therapeutics last reported quarterly earnings on 7/29/2026 (Q2 2026). Earnings per share (EPS) came in at -1.10 USD.

How does Viking Therapeutics stock react to earnings?

Across its last 4 earnings reports, Viking Therapeutics stock moved by ±5.3% on average the following day. The largest reaction was +8% on 10/22/2025; 2 of 4 reactions were positive.

How often has Viking Therapeutics beaten expectations?

Viking Therapeutics has beaten analyst EPS estimates in 1 of its last 5 evaluated quarters (beat rate: 20%).

How do I add the Viking Therapeutics earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$1.07
Actual:
Q2 2026
Beat
Estimate:-$1.23
Actual:-$1.10
Difference:+$0.13
Q1 2026
Missed
Estimate:-$0.98
Actual:-$1.37
Difference:-$0.39
Price reaction (1 day):-0.5 %
Price reaction (7 days):+3.0 %
Q4 2025
Missed
Estimate:-$0.90
Actual:-$1.38
Difference:-$0.48
Price reaction (1 day):+6.8 %
Price reaction (7 days):+5.6 %
Q3 2025
Missed
Estimate:-$0.67
Actual:-$0.81
Difference:-$0.14
Price reaction (1 day):+8.0 %
Price reaction (7 days):+12.1 %
Q1 2025
Missed
Estimate:-$0.44
Actual:-$0.58
Difference:-$0.14
Q4 2024
Estimate:
Actual:
Price reaction (1 day):-6.1 %
Price reaction (7 days):-12.5 %

Earnings statistics

Stock reaction to earnings

±5.3%
Avg. next-day move
+8%
Largest move (10/22/2025)
50%
Share of positive reactions
±8.3%
Avg. move after 7 days

Basis: price reactions to the last 4 report dates (close to close).

Estimates vs. results

1/5
Quarters above estimates
20%
Beat rate
-16.8%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Viking Therapeutics
Ticker Symbol
VKTX
ISIN
US92686J1060
Country
🇺🇸
USA
Sector